Promoters and Institutions in Eris Lifesciences Ltd. have decreased their shareholding, contrasting with the sector averages that show no change in these categories.

Public shareholding has increased, but this is often a reactive measure and does not indicate strong confidence.

The stock's selling trend aligns with the broader sector's stability, highlighting a lack of institutional support compared to the best performers in the sector.